1.0700 -0.03 (-2.73%)
Pre-Market: 7:40AM EDT
|Bid||1.0700 x 27000|
|Ask||1.0900 x 27000|
|Day's Range||1.0300 - 1.1250|
|52 Week Range||0.5100 - 2.4600|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 10, 2021 - May 14, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.88|
In this Motley Fool Live video recorded on April 28, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the best healthcare stocks that Robinhood investors like. Keith Speights: Robinhood stocks have just attracted a lot of attention in recent weeks and months.
Of course, a low share price doesn't necessarily mean a stock is cheap. A high share price doesn't necessarily mean a stock is expensive, either. In many cases, penny stocks (which today include any stock with a share price below $5) are actually valued unattractively.
Aspiring millionaires have been drawn to Tonix Pharmaceuticals (NASDAQ: TNXP), a small clinical-stage biotech with some potential new drugs in development that could be worth billions. Can this company's potential new treatments for fibromyalgia and COVID-19 make millionaires out of bold new investors? To answer this burning question, let's start with this clinical-stage company's lead candidate.